TITLE

rhBMP-2 Induces Transient Bone Resorption Followed by Bone Formation in a Nonhuman Primate Core-Defect Model

AUTHOR(S)
Seeherman, Howard J.; X. Jian Li; Bouxsein, Mary L.; Wozney, John M.
PUB. DATE
February 2010
SOURCE
Journal of Bone & Joint Surgery, American Volume;Feb2010, Vol. 92-A Issue 2, p411
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Bone resorption preceding bone formation has been reported following the administration of recombinant human bone morphogenetic protein-2 (rhBMP-2) delivered in an absorbable collagen sponge (ACS) in metaphyseal bone. This study characterizes treatment with rhBMP-2/ACS in metaphyseal bone with use of a nonhuman primate core-defect model. Methods: Unilateral proximal femoral core defects were treated with 360 μg of rhBMP-2/ACS or ACS alone or were left untreated in seven, five, and five adult male cynomolgus monkeys, respectively. Distal femoral core defects in seven of the above animals were treated with 360 μg of rhBMP-2/ACS in one limb and ACS alone in the contralateral limb. Retention of rhBMP-2 in the proximal part of the femora was determined with use of tracer amounts of 1251-rhBMP-2 imaged with a gamma camera. The distal part of the femora was evaluated with in vivo computed tomography. Computed tomography and histological evaluation were performed on harvested segments in all animals at twenty-four weeks. The histological response in the proximal and distal parts of the femora containing core defects treated with 360 μg of rhBMP-2/ACS in one limb and ACS alone in the contralateral limb was evaluated at one, two, and four weeks in three animals per time point. Results: Approximately 39.9%, 24.2%, 3.4%, and 0.5% of the rhBMP-2 was retained in the proximal part of the femora at one, seven, fourteen, and twenty-one days, respectively. The mineral density and trabecular volume fraction of the core defects treated with rhBMP-2/ACS, those treated with ACS alone, and untreated core defects in the proximal part of the femora were 81%, 54%, and 20%, respectively, and 94%, 36%, and 31%, respectively, of the corresponding region in the contralateral limbs at twenty-four weeks. The mineral density and trabecular volume fraction of the region surrounding the core defects treated with rhBMP-2/ACS, those treated with ACS alone, and untreated core defects were 112%, 105%, and 104%, respectively, and 117%, 108%, and 107%, respectively, of the corresponding region in the contralateral limbs. Treatment with rhBMP-2/ACS increased the size of the proximal and distal core defects compared with treatment with ACS alone. Histological evaluation of the rhBMP-2/ACS-treated limbs demonstrated that bone resorption was initiated at one week in association with osteoclasts and receptor activator of nuclear factor-KB ligand-positive stained spindle-shaped cells and peaked at two weeks. Bone formation was observed at two weeks and was ongoing at twenty-four weeks. Conclusions: Treatment of metaphyseal core defects with rhBMP-2/ACS resulted in bone resorption followed by bone formation in nonhuman primates.
ACCESSION #
48983915

 

Related Articles

  • rhBMP-2 Induces Transient Bone Resorption Followed by Bone Formation in a Nonhuman Primate Core-Defect Model. Seeherman, Howard J.; X. Jian Li; Bouxsein, Mary L.; Wozney, John M. // Journal of Bone & Joint Surgery, American Volume;Feb2010, Vol. 92-A Issue 2, p411 

    Background: Bone resorption preceding bone formation has been reported following the administration of recombinant human bone morphogenetic protein-2 (rhBMP-2) delivered in an absorbable collagen sponge (ACS) in metaphyseal bone. This study characterizes treatment with rhBMP-2/ACS in metaphyseal...

  • Denosumab: recent update in postmenopausal osteoporosis. Silva, Inês; Branco, Jaime C. // Acta Reumatológica Portuguesa;out-dez2012, Vol. 37 Issue 4, p302 

    Postmenopausal osteoporosis is a major concern to public health. Fractures are the major clinical consequence of osteoporosis and are associated with substantial morbidity, mortality and health care costs. Bone strength determinants such as bone mineral density and bone quality parameters are...

  • Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis. Binder, Nikolaus B.; Niederreiter, Birgit; Hoffmann, Oskar; Stange, Richard; Pap, Thomas; Stulnig, Thomas M.; Mack, Matthias; Erben, Reinhold G.; Smolen, Josef S.; Redlich, Kurt // Nature Medicine;Apr2009, Vol. 15 Issue 4, p417 

    Understanding the mechanisms of osteoclastogenesis is crucial for developing new drugs to treat diseases associated with bone loss, such as osteoporosis. Here we report that the C-C chemokine receptor-2 (CCR2) is crucially involved in balancing bone mass. CCR2-knockout mice have high bone mass...

  • Osteoimmunology and the influence of pro-inflammatory cytokines on osteoclasts. Zupan, Janja; Jeras, Matjaž; Marc, Janja // Biochemia Medica;2013, Vol. 23 Issue 1, p43 

    Bone and immune system are functionally interconnected. Immune and bone cells derive from same progenitors in the bone marrow, they share a common microenvironment and are being influenced by similar mediators. The evidence on increased bone resorption associated with inappropriate activation of...

  • Estrogen deficiency inhibits the odonto/osteogenic differentiation of dental pulp stem cells via activation of the NF-κB pathway. Wang, Yanping; Yan, Ming; Yu, Yan; Wu, Jintao; Yu, Jinhua; Fan, Zhipeng // Cell & Tissue Research;Jun2013, Vol. 352 Issue 3, p551 

    Various factors can affect the functions of dental pulp stem cells (DPSCs). However, little knowledge is available about the effects of estrogen deficiency on the differentiation of DPSCs. In this study, an estrogen-deficient rat model was constructed and multi-colony-derived DPSCs were obtained...

  • Intestinal Mucosal Barrier Is Injured by BMP2/4 via Activation of NF-κB Signals after Ischemic Reperfusion. Kang Chen; Wei Xie; Binyu Luo; Weidong Xiao; Teitelbaum, Daniel H.; Hua Yang; Kebin Zhang; Chaojun Zhang // Mediators of Inflammation;2014, p1 

    Intestinal ischemic reperfusion (I/R) can cause dysfunction of the intestinal mucosal barrier; however, the mechanism of the intestinalmucosal barrier dysfunction caused by I/R remains unclear. In this study, using intestinal epithelial cells under anaerobic cultivation and an in vivo rat...

  • Investigation of receptor activator of nuclear factor kappaB ligand and osteoprotegerin levels in multiple sclerosis patients. Kurban, Sevil; Akpinar, Zehra; Mehmetoglu, Idris // Turkish Journal of Biochemistry / Turk Biyokimya Dergisi;Jun2011, Vol. 36 Issue 2, p136 

    Aim: The aim of this study was to investigate the osteoprotegerin (OPG) and receptor activator of nuclear factor kappab ligand (RANKL) levels and their correlation with bone mineral density (BMD) and levels of other bone turnover parameters such as serum osteocalcin, parathyroid hormone (PTH),...

  • Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption. B�n�dicte, Brounais; Carmen, Ruiz V.; Julie, Rousseau; Fran�ois, Lamoureux; Fr�d�ric, Blanchard; Dominique, Heymann; Fran�oise, Redini // Recent Patents on Anti-Cancer Drug Discovery;Nov2008, Vol. 3 Issue 3, p178 

    Tumor cells alter the balanced process of bone formation and bone resorption mediated respectively by osteoblasts and osteoclasts, leading to the disruption of the normal equilibrium and resulting in a spectrum of osteolytic to osteoblastic lesions. This review will summarize research on...

  • Identification of New Targets for Therapy of Osteolytic Bone Disease in Multiple Myeloma. Hjertner, �.; Standal, T.; B�rset, M.; Sundan, A.; Waage, A. // Current Drug Targets;Sep2005, Vol. 6 Issue 6, p701 

    One of the most characteristic features of multiple myeloma is the development of osteolytic bone lesions. Myeloma-associated bone disease is caused by an increase in osteoclastic bone resorption and a decrease in osteoblastic new bone formation. Insight into the molecular mechanisms of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics